Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Spectrum Health Hospitals
Cancer Prevention Pharmaceuticals, Inc.
University of Arizona
University of Hawaii
University of Vermont
Beat NB Cancer Foundation
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals Identifier:
First received: April 24, 2012
Last updated: November 8, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2020
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)